Who owns Ultragenyx Pharmaceutical In?
- CUSIP Number: 90400d958
Tip: Access positions for across all investors
Analyze quarterly positions in Ultragenyx Pharmaceutical In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ultragenyx Pharmaceutical In stock
Who bought or sold Ultragenyx Pharmaceutical In this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Group One Trading | 50k | $1.1M | 377% | Dec 2025 |
|
| Exome Asset Management | 35k | $810k | 100% | Dec 2025 |
|
| IMC-Chicago | 23k | $538k | 100% | Dec 2025 |
|
| Jpmorgan Chase & Co | 3.5k | $105k | 100% | Sep 2025 |
|
Who sold out of Ultragenyx Pharmaceutical In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Silverarc Capital Management | Sep 2025 | 25k | $752k |
| Simplex Trading | Sep 2025 | 23k | $703k |